Not applicableStudy completedNCT02257905What this trial is testingAllo SCT in Amyloidosis Non-interventional StudyWho this might be right forAL Amyloidosis European Society for Blood and Marrow Transplantation 14
Not applicableWithdrawnNCT02812082What this trial is testingWeb-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell TransplantWho this might be right forAllo-SCT PatientsAdult Allo-SCT Survivor Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT02985554What this trial is testingPhase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic MalignanciesWho this might be right forHematologic Malignancies University of Chicago 3
Early research (Phase 1)Ended earlyNCT01551043What this trial is testingAllo CART-19 ProtocolWho this might be right forAcute Lymphocytic Leukemia University of Pennsylvania 2
Not applicableLooking for participantsNCT07537738What this trial is testingLeukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML)MLL Rearrangement Peking University People's Hospital 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199What this trial is testingVenetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCTWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Trapianto di Midollo Osseo 100
Not applicableNot Yet RecruitingNCT07289087What this trial is testingPatient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T TherapyWho this might be right forQuality of LifePatient Reported Outcome (PRO)Allogeneic Blood and Marrow Transplantation (BMT)+1 more Associazione Qol-one 162
Testing effectiveness (Phase 2)Study completedNCT04522895What this trial is testingIDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCTWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+3 more Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)UnknownNCT03454984What this trial is testingSGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell TransplantationWho this might be right forMyelodysplastic SyndromesAcute Myeloid Leukemia Groupe Francophone des Myelodysplasies 40
Not applicableStudy completedNCT04469985What this trial is testingAllogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO SurveyWho this might be right forAllogeneic Stem Cell Transplantation in Elderly Patients Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Testing effectiveness (Phase 2)Study completedNCT03690115What this trial is testingStudy of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML PatientsWho this might be right forLeukemia, Myeloid, Acute Versailles Hospital 23
Large-scale testing (Phase 3)UnknownNCT00002989What this trial is testingCombination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more European Organisation for Research and Treatment of Cancer - EORTC 207
Testing effectiveness (Phase 2)Ended earlyNCT00040417What this trial is testingBone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesWho this might be right forSickle Cell AnemiaHemoglobinopathyThalassemia Baylor College of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT01025505What this trial is testingPh+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational StudyWho this might be right forTreatmentStem Cell Transplantation Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Large-scale testing (Phase 3)Study completedNCT04173533What this trial is testingRandomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCTWho this might be right forAcute Myeloid LeukemiaMyelodysplasia University of Birmingham 326
Not applicableStudy completedNCT04386928What this trial is testingALLO-SCT in Elderly Patients With Hematological DiseaseWho this might be right forHematologic DiseasesStem Cell Transplant Complications Gruppo Italiano Trapianto di Midollo Osseo 1,996
Large-scale testing (Phase 3)UnknownNCT01955772What this trial is testingRandomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.Who this might be right forMyeloablative Allo-SCT University Hospital, Clermont-Ferrand 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953What this trial is testingSafety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT) Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Not applicableStudy completedNCT01687231What this trial is testingInfection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic DietsWho this might be right forHematologic Malignancies Duke University 47
Not applicableLooking for participantsNCT07420790What this trial is testingDesign and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III TrialWho this might be right forAcute Myeloid Leukemia Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,941